Open at the publisher →
In force since 2024-09-01, as the publisher states.
Copy read on 2026-11-10. The page it was read from
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.
sha256 6bc7f9ac7a4cbed3a30dada0104ab681713e9d24049212630f1f1644324d7982
3 provisions
Title and introductory text
2024 No. 838
National Health Service, England
The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2024
Made
at 10.30 a.m. on 30th July 2024
Laid before Parliament
at 1.15 p.m. on 30th July 2024
Coming into force
1st September 2024
The Secretary of State makes the following Regulations in exercise of the powers conferred by sections 164(8A)(a), (8B)(b) and (8D) and 272(7) and (8) of the National Health Service Act 2006.
Propose a change1 Citation, commencement, extent and application
(1) These Regulations may be cited as the National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2024.
(2) These Regulations come into force on 1st September 2024.
(3) These Regulations extend to England and Wales and apply in relation to England only.
Propose a change2 Amendment of regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013
(1) Regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (zero or nominal product reimbursement for coronavirus vaccines and antivirals) is amended as follows.
(2) In its heading, omit “coronavirus”.
(3) In paragraph (2)—
(a) in sub-paragraph (a), omit “(“a coronavirus vaccine”)”;
(b) omit “or” at the end of sub-paragraph (a); and
(c) after sub-paragraph (a) insert—
(aa) a drug or medicine which is used for vaccinating or immunising people against respiratory syncytial virus, if the conditions set out in paragraph (3) are satisfied;
(ab) a drug or medicine which is used for vaccinating or immunising people against measles, mumps and rubella, if the conditions set out in paragraph (3) are satisfied; or
.
(4) In paragraph (3)—
(a) in sub-paragraphs (a) to (c), for “coronavirus” substitute “the” at each place where it occurs (three times); and
(b) in sub-paragraph (d), omit “coronavirus”.
(5) After paragraph (3), insert—
(3A) The references in paragraph (3) to vaccines or the vaccine in question are references to the drugs or medicines in respect of which the conditions set out in paragraph (3) are to be satisfied by virtue of paragraph (2)(a) to (ab).
.
Propose a change